RTI.H — Radient Technologies Income Statement
0.000.00%
HealthcareMicro Cap
Annual income statement for Radient Technologies, fiscal year end - March 31st, CAD millions except per share, conversion factor applied.
C2018 March 31st | 2019 March 31st | 2020 March 31st | 2021 March 31st | 2022 March 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | ARS | ARS | ARS | ARS | ARS |
Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 0.456 | 0.214 | 18.4 | 2.49 | 3.62 |
Cost of Revenue | |||||
Gross Profit | 0.195 | 0.083 | 0.448 | -0.496 | 0.188 |
Selling / General / Administrative Expenses | |||||
Research And Development | |||||
Depreciation and Amortization | |||||
Unusual Expense / Income | |||||
Other Operating Expenses | |||||
Total Operating Expenses | 8.35 | 18.2 | 53.4 | 42.8 | 16.6 |
Operating Profit | -7.9 | -18 | -35 | -40.3 | -13 |
Total Net Non Operating Interest Income / Expense | |||||
Gain / Loss on Sale of Assets | |||||
Total Net Non Operating Interest Income / Expense | |||||
Other Net Non Operating Costs | |||||
Net Income Before Taxes | -14 | -27.9 | -37.4 | -42.3 | -12.9 |
Net Income After Taxes | -14 | -27.9 | -37.4 | -42.3 | -12.9 |
Net Income Before Extraordinary Items | |||||
Net Income | -14 | -27.9 | -37.4 | -42.3 | -12.9 |
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Diluted Net Income | -14 | -27.9 | -37.4 | -42.3 | -12.9 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | -0.074 | -0.112 | -0.098 | -0.052 | -0.019 |